NEW YORK (GenomeWeb) – Angle announced today a conditional placing and subscription intended to raise £12 million ($15.9 million) in gross proceeds. 

The UK firm plans to place roughly 24 million ordinary shares at 50 pence per share, and subscriber who is a member of the firm's staff, plans to subscribe for 30,000 new ordinary shares at 50 pence per share. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.